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Abstract

Persister cells comprise a phenotypic variant that shows extreme antibiotic tolerance
resulting in chronic infections. While this phenomenon has posed a great threat in public health,
mechanism underlying their formation in Staphylococcus aureus remains largely unknown.
Increasing evidence of the presence of persister cells in recalcitrant infections underscores the
great urgency to unravel the mechanism by which these cells are developed. The Elasri Research
group characterized msaABCR operon that plays roles in regulation of virulence, biofilm
development and antibiotic resistance. It was hypothesized that the operon also plays a role in
persister cell formation. In this study, the persister cell fraction in wild type (WT) USA300 LAC,
its isogenic msaABCR deletion mutant (ΔmsaABCR) and complemented operon mutant
(complement) strains were compared. The present study shows that the ΔmsaABCR forms fewer
persister cells as compared to WT challenged with various antibiotics single as well as in the
combinations in exponential as well as in the stationary phase. The complement restored the
phenotype as comparable to the WT in most of the drug tested. Likewise, the ΔmsaABCR also
formed less number of persister cells challenged with gentamycin in the presence of metabolite
fructose. Taken together, this study suggests that msaABCR plays role in the persister formation.
Ultimately, the goal is to define the mechanism that causes msaABCR to control persistence. This
study will bring new insights into the understanding of persister cells formation and
consequently overcome failures of staphylococcal infections.
Key Words: Persister cells, Staphylococcus aureus, msaABCR operon, metabolite, antibiotics
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Chapter 1: Introduction
In 1944, Bigger discovered small fraction of Staphylococcal cells survived the penicillin
treatment that resumed their growth upon removal of the drug, which he termed as persister cells.
Bacterial resistance and tolerance to antibiotics lead to treatment failures of many infections.
Antibiotic resistance often stems from genetic changes, whereas antibiotic tolerance is a property
of a small fraction of phenotypic variants called persister cells. Persister cells undergo dormancy
and hence survive antibiotic treatment due to their lack of metabolism, rather than due to genetic
changes (Keren, Kaldalu, Spoering, Wang, & Lewis, 2003). Mechanism of persister formation in
S. aureus is still not understood. Increasing evidences suggest that there is presence of persister
cells in recalcitrant bacterial infections (Conon BP., 2014). Persister cells show extreme
tolerance to antibiotics (Keren et al., 2004), have little or no cell wall synthesis, and other
cellular processes. In tolerant persister cells, antibiotics can bind to the target, but cannot alter it,
so no corrupted product is produced, thus cells are not killed. When the antibiotic is removed, the
persister cells awake from their dormant state, resume growth and form the regular cells (Lewis
K., 2007).
The genetics behind the development of persister cells continues to be researched. A
newly characterized operon msaABCR has been found to play a role in biofilm formation,
virulence, and antibiotic resistance. Hence, it was hypothesized that msaABCR operon may also
play a role in the development of antibiotic tolerant persister cells. In this study, the number of
persister cells formed in the WT USA300 LAC, its isogenic ΔmsaABCR strain, and the
complement in single as well as with the combination of different antibiotics was compared.
Also, the number of persister cells challenged with aminoglycoside mainly gentamicin in the
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presence of metabolites was compared. This was done to determine the effect of different
metabolites that enhance the uptake of aminoglycoside to kill persister cells.
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Chapter 2: Literature Review
Mechanism of Persister Formation
Persister cells are a subpopulation of bacteria that are multi-drug tolerant and contribute
to chronic and recalcitrant clinical infections such as cystic fibrosis, tuberculosis, pneumonia and
invasive infections caused by variety of bacterial pathogens. Persisters are metabolically dormant
which makes the cells highly tolerant to traditional antibiotics that are mainly effective against
actively growing cells (Kwan, Chowdhury, & Wood, 2015). Persister cells have been discovered
to be in high numbers in bacterial biofilms. These cells are believed to be associated with the
antibiotic tolerance and reoccurrence infections caused by biofilm producing pathogens.
(Fauvart, Groote, & Michiels, 2011). Mechanism of formation of persister cells in S. aureus is
not well understood. However, a recent study showed that persisters in S. aureus are associated
with depletion of ATP. In the exponential phase, fewer persister cells are formed and were found
to enter the stationary phase early with the depletion of ATP (Conlon BP, 2016). The fraction of
persister cells increases as the cells enter the stationary phase. Biofilm harbors more number of
persister cells, protecting them from immune invasions and antibiotic effects leading to
detrimental antimicrobial challenge and cause the regrowth of the biofilm associated infections
(Roberts & Stewart, 2005).
In a recent study, several genes were confirmed to be associated with persister cells
formation in S. aureus, including hemB, mazF, and glpK (Fu et al., 2009; Singh et al., 2009; Han
et al., 2014; Wang, et al., 2015). It was also found that ureG, sdhA, and sdhB were associated
with persister cell formation in S. aureus under treatment with levofloxacin (Wang, et al., 2015).
Also, new evidence has been found that associates a drop in intracellular adenosine triphosphate
(ATP) with S. aureus persister cells production into the stationary phase. Levels of ATP in the

3

cell have been found to be predictive of bactericidal antibiotic efficacy and explain bacterial
tolerance to antibiotics (Conlon, Rowe, Gandt, Nuxoll, Zalis, & Lewis, 2016).
Isolation of Persister Cells
The first method to isolate persisters was based on the simple sedimentation of surviving
cells from a culture that had been lysed with ampicillin antibiotic treatment (Lewis, 2007).
Lewis’s study allowed specific genes to be identified that could have contributed to the dormant
phenotype: rmf stationary state inhibitor of translation; sulA, an inhibitor of septation; as well as
toxin-antitoxin (TA) loci relBE, dinJ and mazEF (Lewis, 2007). Because persister cells are in
their highest frequency during the stationary phase of growth (Lewis, 2007), this phase is an
ideal time to isolate and run tests on the cells. The stationary phase is the phase in which the
number of dividing cells and the number of dying cells are equal in number in the media. At this
point, the amount of nutrients that are being consumed and the toxic wastes of the organisms are
accumulating. Because persister cells are slow growing or non-growing cells that form more
readily under growth limiting conditions (Fauvart, Groote, & Michiels, 2011), this now nutrient
limited environment is ideal for studying the presence of persister cells.
Staphylococcus aureus: Organism of Study
S. aureus, is an opportunistic pathogen that causes many diseases that affect the human
population. The diseases that S. aureus cause are often chronic and recalcitrant to many common
antibiotic treatments (Conlon B. P., 2014). Community-acquired, methicillin-resistant S.
aureus strains cause localized infections in immune-compromised hosts. In addition, some
strains show superior virulence that leads to severe infections even among healthy individuals
with no predisposing risk factors (Sahukhal, 2014). S. aureus can form biofilms, which have
been linked to many diseases. The bacteria biofilms are sheathed in a polysaccharide glycocalyx
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which in turn provides the bacteria with protection against the host’s immune defenses and
antimicrobial drugs (Sambanthamoorthy, Schwartz, & Nagarajan, 2008). Infections that are
ascribed to biofilms include but are not limited to childhood middle ear infection, gingivitis, and
infections of indwelling devices such as catheters, orthopedic prostheses, and heart valves. It has
been found that stationary- state cultures of S. aureus produce large populations of persisters
(Keren, Kaldalu, Spoering, Wang, & Lewis, 2003). Therefore, studying the virulence factors and
the regulators which are believed to contribute to persister cell formation and that are responsible
for the development of chronic S. aureus infection is essential and can be used as a basis for
treatment development.
msaABCR Operon
The msaC gene had been identified as a regulator of sarA, agr, and many other virulence
factors (Sahukhal, 2014). The staphylococcal accessory regulator, sarA, is a major global
regulator that is essential for biofilm formation both in vitro and in vivo (Sambanthamoorthy,
Schwartz, & Nagarajan, 2008). In a study done by Sambanthamoorthy, Schwartz and Nagarajan,
the msa gene was mutated and the biofilm formation was observed. The study determined that
mutation of the msa gene in strain of S. aureus resulted in a weak biofilm at the accumulation
stage resulting in an immature biofilm. This defect was likely mediated by the reduced
expression of sarA in the msa mutant (Sambanthamoorthy, Schwartz, & Nagarajan, 2008). The
results suggested that the weak biofilm defect in the msa mutant was an intermediate phenotype
between the sarA mutant and wild-type (Sambanthamoorthy, Schwartz, & Nagarajan, 2008). It
was discovered that the msaABCR operon was vital in the regulation of virulence and the
development of biofilms in S. aureus. The two RNAs that were found to regulate the expression
of the msaABCR operon are msaC and msaR (Sahukhal, 2014).
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Because the msaABCR operon has been found to regulate the virulence and biofilm
development of S. aureus, it is reasonable to study the potential relationship between the
formation of persister cells and the msaABCR operon. Therefore, in the present study, the goal is
to compare the number of persister cells formed by wild-type S. aureus and the ΔmsaABCR
challenged with aminoglycoside enabled with metabolites and different combination of
antibiotics.
Biphasic Killing Curve
Persister cells are phenotypic variants of the normal cells which show multidrug tolerance
to antibiotics (Percival, Hill, Malic, Thomas, & Williams, 2011). When a bacterial population is
treated with antibiotics, majority of the cells are killed leaving behind small fraction of cells
showing a plateau with no or slow growth for extended period (Fauvart, Groote, & Michiels, 2011).
This biphasic killing curve is characteristic of persister cells and depends on the drug used
(Fig.1). Upon, removal of the antibiotics, persister cells resume their growth and form the normal
population, mechanism by which persister cells cause the relapsing infections (Lewis K, 2010).
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Figure 1. “Biphasic killing pattern in response to antibiotics. Addition of increasing concentrations of
antibiotics and/or increasing the treatment duration leads to an initial phase of rapid killing of the bulk
population. However, beyond a certain threshold (indicated by a dashed vertical line), a killing plateau is
observed as only persister cells remain viable.” (Fauvart, Groote, & Michiels, 2011)

Antibiotic Tolerance
Chronic infections are paradoxically caused by antibiotic sensitive persisters which show
transient multidrug tolerance by slowing down their metabolic state and entering dormancy.
Antibiotics kill the cells by binding to the active bacterial targets and producing the corrupted
product, which are toxic to the cell viability. In antibiotic resistance, the antibiotic is prevented to
bind to the target. But in antibiotic tolerance, antibiotics can bind to the target but cannot form
the corrupted product; hence the cells are intact in in antibiotic tolerance Fig. 2.A (Lewis K.,
2010). This idea that persister cells are tolerant rather than resistant has led to the suggestion that
persisters are specialized survivor cells (Keren, Kaldalu, Spoering, Wang, & Lewis, 2003).
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Figure 2. A) Resistance versus Tolerance
Biofilm
Persister cells are found in higher number in staphylococcal biofilm infections. Biofilm
acts as a protective layer against the host immune responses and antibiotic treatment which has
been hypothesized to be an important determinant in biofilm tolerance to drugs and other host
defense factors. The altered physiology of biofilm on the other hand reflects the unique
environmental niche and high cell density, which is likely to limit nutrient and oxygen availability,
forcing the subset of biofilm cells into a stationary and persister-like state. Cells in this physiology
are primed to survive wide-ranging environmental insults including antibiotic challenge (Conlon
BP., Rowe SE and Lewis K., 2014). During biofilm infections, cells are killed via antibiotic or
host immune defenses but small fraction of cells remain untouched inside the biofilm. On removal
of the antibiotic treatment, these persister cells resume their growth and relapse the infection Fig.
2B. (Lewis K., 2010)
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Figure 2.B) Model for relapsing biofilms. (Lewis.K, 2010)
Persister Cells and Infections
In the past, a variety of antibiotics were used to the treat S. aureus infections, and soon
became inactive treatments due to the extreme adaptability of the bacteria and its ability to
develop resistance and/or tolerance. Antibiotics used today include vancomycin, rifampicin, and
gentamicin. Recently, teixobactin, a new antibiotic, was discovered to have a significant impact
on the treatment of S. aureus and other gram-positive and drug- resistant strains of bacteria. It
was found to strongly inhibit synthesis of peptidoglycan, and there has been no sign of the
development of resistance which suggests that it is not a protein (Ling, 2015). The exploration of
antibiotics that not only affect the normal cell population, but that also have the capacity to
eradicate persister cells is essential, and provides the basis for the present study.
Metabolism as a Means for Persister Eradication
As with all cells, bacterial cells function and survive by means of metabolism. However,
persister cells are traditionally metabolically dormant cells which make them difficult to treat
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with most antibiotics. (Kwan, Chowdhury, & Wood, 2015). In a study conducted by Allison,
Brynildsen &Collins, metabolic stimuli were shown to enable the killing of persister cells via
aminoglycosides which bind to the ribosome and cause the cells to die by mistranslation of RNA.
This enabling of killing was reasoned to be due to an increase in the proton-motive force (PMF)
which facilitates the uptake of aminoglycosides, a type of antibiotic (Allison, Brynildsen, &
Collins, 2011). Mitchell’s chemiosmotic hypothesis stated that the proton motive force was the
driving force for energy-requiring processes such as solute transport and ATP synthesis
(Mitchell, 1966). In a study conducted by Taber, Mueller, and Miller, it was determined that
aminoglycoside uptake requires energy; bacterial cells take up aminoglycosides against a
concentration gradient. The mechanisms by which this occur remains ambiguous, but after
conducting the current study, a relationship between the aminoglycoside uptake and the
ΔmsaABCR operon may be determined which could lead to the further exploration of the
mechanism on the molecular level.
In the study conducted by Allison, Brynildsen and Collins, it was proposed that certain
metabolites such as glucose, fructose, and mannitol were transported into the cytoplasm by
phosphotransferase system enzymes (Allison, Brynildsen, & Collins, 2011). After entering
glycolysis where NADH is generated, NADH is oxidized by enzymes in the electron transport
chain that in turn contributes to PMF. These now increased levels of PMF facilitate the uptake of
aminoglycosides which leads to cell death (Allison, Brynildsen, & Collins, 2011). This process
can be seen in Figure 3. The results from their study on the metabolite-enabled killing off
persister cells that showed the potentiation of each of the sugars tested can be seen in Figure 4.
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Figure 3. Mechanism for metabolite eradication of persisters (a). Metabolite-enabled eradication of
persisters occurs via the catabolism of carbon sources (i.e. glucose, fructose, mannitol) which generates
NADH. NADH is oxidized by the electron transport chain that contributes to PMF, which facilitates the
uptake of aminoglycosides that leads to persister cell death. (Allison, Brynildsen, & Collins, 2011)

Figure 4. Metabolite- enabled killing of persister cells. (Allison, Brynildsen, & Collins, 2011)

11

Chapter 3: Methods
Bacterial strain and Culture Preparation
Overnight cultures of bacterial strains USA300 LAC, isogenic msaABCR mutant strain,
and its complement strain were prepared by inoculating small fraction of frozen stock into 5 mL
Muller and Hinton Broth (MHB) in 17X100 mm culture tubes for 16 hours with continuous
aeration at 225 RPM at 37˚C. The overnight cultures were diluted 1:10 and incubated further for
2 hours, and then normalized to OD600 0.02 in warmed 10 mL MHB to use as the starting culture.
Exponential phase cells were prepared by incubating starting cultures for ~2 hours until they
reached an OD600 of 0.5. Stationary phase cells were prepared by inoculating 1μL of starting
culture in 10 mL MHB for 16 hours.
Media Preparation
The Mueller Hinton Broth (MHB) and Luria Burtani Broth were prepared as
manufacturer’s instruction. After thoroughly mixing media in distilled water, the bottles were
vented by slightly untwisting the cap, and then autoclaved. The media cooled before it was used
to prepare cultures.
Equal Cell Counts
To determine when the growth was reached the desired OD, 100µl of the culture was
diluted into 900µl of PBS when using LB. Using the spectrophotometer, the OD of the cells was
measured. Upon receiving the OD, the volume of each culture that needed to be added to the
fresh media was calculated using the following equation:
𝐷𝑒𝑠𝑖𝑟𝑒𝑑 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 × 𝑃𝑟𝑒𝑝𝑎𝑟𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑚𝑒𝑑𝑖𝑎
𝑂𝐷

× 1000 μL
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Metabolite Assay
After equal cell counts were achieved, the cultures grew an additional two hours. Then,
the initial cell count was taken and plated prior to the addition of the stressors (metabolite or
aminoglycoside or both). After the initial cell count was taken, culture was treated with 10µg/mL
of Gentamycin combined with 0.05% of the desired metabolite (fructose, mannitol, glucose,
arabinose, ribose, rhamnose). The cultures grew for two hours. Starting at the two-hour mark and
continuing bi-hourly for eight hours, the CFU count was taken via the plating of 100µl of each
sample onto a TSA plate. The same procedure was followed as with the control group (with
sugar only) with the CFU count being taken bi-hourly for eight hours via plating onto TSA
plates. The colonies grew overnight and were counted the next day.
Antibiotic Assay
Exponential phase cells were plated for colony forming units (CFU) counts and
challenged with the antibiotics daptomycin (10 µg/ml, 10 MIC), vancomycin (25 µg/ml, 40
MIC), linezolid (50 µg/ml, 10 MIC), gentamicin (50 µg/ml, 10 MIC), and rifampicin (2.4
µg/ml, 40 MIC). These concentrations were the minimum concentrations showing similar
killing kinetics to that of higher concentrations of the respective antibiotics. At designated time
point of each antibiotic, 100μL of cells was removed, washed with 1X phosphate buffer saline
(PBS) and plated for CFU counts after 24 hrs. Stationary phase cells were plated for initial CFU
count and persister cells were enumerated as above at designated time points after adding
different concentration of antibiotics in combinations (Table 1). Persister assays were performed
as above in exponential as well as stationary phase cells challenged with combination of the
antibiotics. The colonies grew overnight and were counted the next day.

13

Antibiotic Concentrations used (Exponential)
DAP+RIF
1.24μg/mL 0.312μg/mL
VAN + RIF
3.12μg/mL 0.074μg/mL
LIN + RIF
3.12μg/mL 0.074μg/mL
DAP + GEN
6.24μg/mL 25μg/mL
VAN + GEN
6.24μg/mL 25μg/mL
LIN + GEN
6.24μg/mL 50ug/mL
Antibiotic Concentrations used (Stationary)
DAP+RIF
1.24μg/mL 0.312μg/mL
VAN + RIF
3.12μg/mL 0.074μg/mL
LIN + RIF
3.12μg/mL 0.074μg/mL
DAP + GEN
6.24μg/mL 25μg/mL
VAN + GEN
6.24μg/mL 25μg/mL
LIN + GEN
6.24μg/mL 50ug/mL

MIC
0.0312+0.0078
0.156+0.0037
0.156+0.0037
0.312+1.25
0.312+1.25
0.312+2.5
0.0312+0.0078
0.156+0.0037
0.156+0.0037
0.312+1.25
0.312+1.25
0.312+2.5

Table 1: Concentration of antibiotic used
Dilutions
To complete the dilutions, 100µl aliquots of each experimental culture (those that were
treated with the gentamycin and a carbon source) as well as the control cultures (those that have
not been treated with gentamycin and a carbon source) were re-suspended in 900µl of PBS and
labeled. These initial dilutions were centrifuged at 10,000 RPMs for 5 minutes. Once removed,
700µL of the supernatant was removed from the top and disposed. Then, 700µL of PBS was
added back to the culture and mixed well via vortex for approximately 10 seconds to assure an
even mix. Then, each tube was serially diluted 10-fold, by extracting 100µL of the culture from
the initial tubes and serially diluting it into 900µL tubes of PBS. This was repeated until 5
dilutions were made for each original culture. Upon completing the serial dilutions, the cells
were plated onto TSA agar plates using the spreading method. This method of serial dilution was
repeated for each strain exposed to a carbon source and the aminoglycoside.
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Plating and counting
To plate, 100µl of each dilution from the second dilution to the fifth was separately
plated on an individual TSA agar plate. Using a pipette, 100µL of each sample was added to a
plate and spread around the plate using a spreader. Once the sample no longer appeared moist on
the agar, the top was replaced and the plate was inverted and incubated at 37˚C overnight. After
the incubation period, the CFUs were counted and compared to the number of CFUs from the
control.
Determining Persister Cells
The number of colony forming units (CFUs) per milliliter after exposure to different
antibiotics was measured. Persister (surviving fraction) was calculated after incubation by
dividing the number of cfu/mL in the culture with the antibiotic by the number of cfu/mL in the
culture before adding the antibiotic. The CFUs was counted at designated time points (i.e. 2
hours, 4hours…). The equation used is show below.
𝐶𝐹𝑈
𝑁𝑜 𝑜𝑓 𝑚𝐿 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐
𝐶𝐹𝑈
𝑁𝑜 𝑜𝑓 𝑚𝐿 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑏𝑒𝑓𝑜𝑟𝑒 𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐
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Chapter 4: Results
Metabolite with Aminoglycoside
The treatment of the ΔmsaABCR strain with aminoglycosides and metabolites did show a
further decrease in cell death in comparison to the WT USA300 LAC. There were seven sugars
(fructose, glucose, mannitol, pyruvate, arabinose, rhamnose, and ribose) used in each media and
combined with gentamycin. In the LB media, fructose showed good potentiation in gentamycin
treatment that most of the persisters were eradicated in the ΔmsaABCR and a considerable
number of persisters remained in the USA300 LAC. However, in this assay, the complement did
not show the resumption of phenotype comparable to the WT strain (Fig. 4). The test with only
fructose and gentamycin, no killing was seen in all the three strains tested (Fig. 5 and 6).

Survival Fraction

0.04
0.03
0.02

LAC
msaABCR

12.36

0.01

Complement
0
LAC

msaABCR

Complement

Gentamycin with Fructose

Figure 5. Gentamycin with fructose. There is a significant decline in the number of persisters found in
ΔmsaABCR (red) strain of S. aureus which expresses that on average most of the persisters were
eradicated and shows a potential relationship between the uptake of the aminoglycoside and the
msaABCR operon.
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No. of CFUs
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1.00E+06
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ΔmsaABCR
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8

Incubation time (hour)

Figure 6. Gentamycin (10μl/without fructose). When gentamycin is used alone to treat the
S. aureus population, there is no killing of persister cells in neither the wild-type LAC (blue), the

No of CFUs

operon mutant ΔmsaABCR (red), nor the complement strain (green).

1.00E+09
1.00E+08
1.00E+07
1.00E+06
1.00E+05
1.00E+04
1.00E+03
1.00E+02
1.00E+01
1.00E+00

LAC
ΔmsaABCR
Complement
IC

2

4

6

8

10

Incubation time (hour)

Figure 7. Fructose Only. When fructose is used alone to treat the S. aureus population, there is
little killing of persister cells in neither the wild-type LAC (blue), the operon mutant ΔmsaABCR
(red), nor the complement strain (green).
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Antibiotic Assay
The treatment of the ΔmsaABCR strain with different combinations of antibiotics showed
an overall decrease in persister cells when compared to the USA300 LAC. There were five
antibiotics used rifampicin, gentamycin, vancomycin, daptomycin, and linezolid. When
vancomycin and rifampicin were combined, ΔmsaABCR generated more than 2 log fold
decreased number of persister cells as compared to the WT (Fig.9), and the stationary growth
phase formed 4.04-fold less number of persister cells than WT at 48 hours (Fig. 10). When
daptomycin and rifampicin were combined, the exponential growth phase showed reduced
number of persister cells by 48.40fold compared to wild-type (Fig. 11), and while it decreased by
16.6-fold than wild-type in stationary phase after 48 hours of treatment (Fig. 12). With the
combination of linezolid and gentamycin, ΔmsaABCR showed 22.5fold less number of persister
cells than wild-type at 24 hours (Fig. 13), and the stationary growth phase showed less by 9.5fold than wild-type at 48 hours of antibiotic treatment (Fig. 14).

1.00E+11

CFU Count (cfu/ml)

1.00E+10
1.00E+09
1.00E+08

LAC

1.00E+07

ΔmsaABCR

1.00E+06

Complement

1.00E+05
1.00E+04

1

2

3

4

(Days)

Figure 8. Growth Curve for the stationary growth phase for each of the S. aureus strains LAC (blue),
ΔmsaABCR mutant (red), and complement (green) in the absence of antibiotics or other stimuli.
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Figure 9. Exponential growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with vancomycin at 3.12µg/mL concentration and
rifampicin at 0.074µg/mL concentration. ΔmsaABCR expressed change by 2-fold l/m less than wild-type
(LAC) at 72 hours.
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Figure 10. Stationary growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with vancomycin at 3.12µg/mL concentration and
rifampicin at 0.074µg/mL concentration. ΔmsaABCR expressed change by 4.04-fold l/m less than wildtype (LAC) at 48 hours.
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Figure 11. Exponential growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with daptomycin at 1.24µg/mL concentration and rifampicin
at 0.312µg/mL concentration. ΔmsaABCR expressed change by 48.40-fold l/m less than wild-type (LAC)
at 48 hours.
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Figure 12. Stationary growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with daptomycin at 1.24µg/mL concentration and rifampicin
at 0.312µg/mL concentration. ΔmsaABCR expressed change by 16.6-fold l/m less than wild-type (LAC)
at 48 hours.
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Figure 13. Exponential growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with linezolid at 6.24µg/mL concentration and gentamycin
at 50µg/mL concentration. ΔmsaABCR expressed change by 22.5-fold l/m greater than wild-type (LAC)
at 24 hours.
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Figure 14. Stationary growth phase results when the three S. aureus strains LAC (blue), ΔmsaABCR
mutant (red), complement (green) are treated with linezolid at 6.24µg/mL concentration and gentamycin
50µg/mL concentration. ΔmsaABCR expressed change by 9.5-fold l/m less than wild-type (LAC) at 48
hours.
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Chapter 5: Discussion and Conclusion
In the study, seven sugars were used to determine the metabolite eradication of persister
cells in S. aureus via the aminoglycoside, gentamycin. The results from the test conducted
without the aminoglycoside shows a constant growth and death rate over time, and then a
dramatic decline in the number of cells in the sample. This dramatic change occurred as the cells
continued to consume the sugar while growing in the media. Once the cells reached the
stationary phase, the amount of sugars consumed and the amount of waste produced increased.
This depletion of healthy nutrients and accumulation of toxins lead to an increase in cell death. It
is believed that the additional sugar added to the growth media cause the cells to grow and
replicate at a much faster rate which lead to the viable cells in the culture reaching the stationary
phase sooner.
The result from the test conducted without the metabolite showed a constant growth and
death rate over time. In this case, the aminoglycoside could only kill the viable cells leaving the
persister cells to maintain the culture. This occurred because of the aminoglycosides weak
activity against dormant cells which was mentioned in the study by Allison, Brynildsen, and
Collins. Aminoglycoside activity requires energy and therefore needs a metabolite to stimulate
the cell to uptake the aminoglycoside, without this stimulant, the aminoglycoside remains
ineffective against normally metabolically dormant cells such as persister cells.
In the LB media, there was little potentiation in glucose, pyruvate, arabinose, rhamnose,
ribose, and mannitol. Some of the sugars showed no effect on either strain, while some of the
sugars seemed only to affect the wild-type strain. However, fructose showed good potentiation in
the LB media and showed the killing of the persisters in the ΔmsaABCR operon over the wildtype and the complement. These results are consistent with the results in Allison, Brynildsen, and
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Collin’s study in that gentamycin and fructose reduce the viability of cells in S. aureus. The
results obtained from this part of the study illustrate the relationship between the uptake of
aminoglycosides into cells and the role of the msaABCR in cell death.
It can be concluded that the msaABCR coordinated with fructose and gentamycin further
increased persister cell death. In the future, the results from this study may be used to determine
the mechanism by which the msaABCR operon codes for virulence factors in S. aureus that lead
to recurrent infections. Also, the results from this study can be used to develop medicines that
can be used to treat chronic S. aureus infections.
In the study, five different antibiotics were used and combined in varying manners. The
combinations included vancomycin and rifampicin, daptomycin and rifampicin, linezolid and
gentamycin, rifampicin and vancomycin. The results for each combination showed an increase in
persister cell death with the ΔmsaABCR strain having increased persister cell death in majority of
the samples. Daptomycin and rifampicin when combined was found to play a significant role on
the eradication of persisters in S. aureus in the ΔmsaABCR strain by showing a drastic 48.40-fold
l/m decrease in persister cells from the wild-type. Also, rifampicin and vancomycin showed a
significant decrease in persister cells in the mutant S. aureus. In the assay with linezolid and
gentamycin, the exponential growth phase for the ΔmsaABCR strain changed by a 22.5-fold l/m
increase in persister cells from the wild-type.
In this study both the exponential growth phase and stationary growth phase were
explored because there are two types of persisters. The results of this study showed that the
greatest declines in the mutant persister cell populations were expressed in the exponential
growth phase for each of the antibiotic combinations except linezolid and gentamycin. This
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emphasis on persister cell death shows that the different combinations of antibiotics act more
readily on persister cells present while the culture is proliferating.
It can be concluded that the antibiotics used in this study with the exception of the
linezolid and gentamycin combinations work more effectively in a nutrient-rich environment.
The results of this study can be used in future studies to develop effective antibiotic treatments
for eradication of persister cell populations.
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